.jpg)
1 hour ago
3
Article content
Under the theme
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
“
Article content
Article content
One Roquette for Innovations,” the company will highlight its recently expanded portfolio to demonstrate how this unmatched range of high-performance excipients and innovative formulation solutions is powering the next generation of pharmaceuticals.
Article content
SHANGHAI — Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, will showcase its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026, taking place June 16-18 at the Shanghai New International Expo Centre (SNIEC). Under the theme “One Roquette for Innovations,” Roquette’s Health & Pharma Solutions Business Unit will exhibit at booth E3D26, highlighting how its deep scientific expertise and technical capabilities enable pharmaceutical companies to turn promising formulations into scalable commercial realities.
Article content
Article content
Article content
“As the pharmaceutical industry accelerates innovation, from GLP-1 therapies to complex biologics, the pressure to deliver manufacturing reliability, consistent supply, and robust formulations at scale has never been greater,” said Angela Strzelecki, Senior Vice President of the Roquette Group and CEO of Roquette’s Health & Pharma Solutions Business Unit. “At Roquette, we are uniquely positioned to address these challenges through our integrated portfolio spanning excipients, formulation technologies, biopharmaceutical solutions, and hard capsules. With a wide manufacturing network and global quality standards, we are committed to being the trusted partner that powers the next generation of drug delivery in China and the Asia Pacific region.”
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
PEARLITOL® Mannitol: Enabling Scalable, Modern Drug Delivery
Article content
Roquette’s PEARLITOL® mannitol, a versatile excipient designed to simplify formulation development while maintaining exceptional performance at scale, will be showcased at the booth. Manufactured in China to support reliable regional supply, PEARLITOL® mannitol enables:
Article content
- High and low dose formulations across a wide range of dosage forms
- Enhanced stability in sensitive conditions
- Reliable processability and batch-to-batch consistency
- Flexibility across oral, injectable, inhalation, and biologic applications
Article content
Integrated Solutions for Every Stage of Drug Development
Article content
- Roquette’s booth will feature its complete range of pharmaceutical solutions designed to address the industry’s most pressing challenges:
- High-performance pharmaceutical excipients: including Avicel® microcrystalline cellulose, Ac-Di-Sol® croscarmellose sodium, METHOCEL™ HPMC, ETHOCEL™ ethylcellulose, and POLYOX™ polyethylene oxide
- Differentiated formulation technologies: across oral solid dosage forms, controlled release systems, and complex specialty formulations
- Biopharmaceutical solutions: including KLEPTOSE® beta-cyclodextrins for protein stabilization and NOVAMATRIX-3D™ alginate foams for 3D cell culture
- Hard capsules and integrated delivery solutions: Qualicaps by Roquette offers a full range of HPMC and gelatin capsules for oral and inhalation applications
- End-to-end support: expertise spanning from early formulation development to commercial manufacturing scale-up
Article content
Connect with Roquette at CPHI China 2026
Article content
Article content
Visit Roquette at booth E3D26 to meet with its team of experts and learn how its integrated solutions can help you overcome formulation complexity and scaling challenges. For more information about Roquette’s participation at CPHI China 2026, click here.
Article content
About Roquette
Article content
Roquette is a global leader in sustainable plant-based solutions, driving innovation and strong partnerships that are shaping the future of nutrition, health, and bioindustry.
Article content
The company harnesses natural resources such as wheat, corn, seaweed, and cellulose to craft high-performance ingredients used in everyday foods, oral medications, advanced biopharmaceuticals, and a range of bio-based products.
Article content
A family-owned company with over 90 years of expertise and 11,000 employees, Roquette serves clients in over 150 countries and is committed to creating lasting value for customers, patients, consumers, and society.
Article content
Together, we turn the potential of nature into the essentials of life.
Article content
Discover more about Roquette here.
Article content
Article content
Article content
Article content
View source version on businesswire.com:
Article content
Article content
Article content
Contacts
Article content
Press Contact
Article content
Article content
Lisa Luke
Article content
Article content
Global Head of Communications
Article content
Article content
Roquette’s Health & Pharma Solutions Business Unit
Article content
Article content
Email:
Article content
Article content
English (US)